Coca-Cola EP PLC - Result of AGM
The Annual General Meeting of
All 30 resolutions put to the members were passed on a poll. Accordingly, resolutions 1 to 25 were passed as ordinary resolutions and resolutions 26 to 30 were passed as special resolutions.
The results of the polls are set out below:
Resolution |
For (see note 1) |
Against (see note 1) |
Issued share capital represented by votes (see note 2) % |
Votes withheld (see note 3) |
|||
Votes |
% |
Votes |
% |
||||
1 |
Receipt of the Report and Accounts |
401,608,982 |
99.99 |
26,657 |
0.01 |
87.53 |
128,634 |
2 |
Approval of the Directors' Remuneration Policy |
398,060,389 |
99.10 |
3,633,330 |
0.90 |
87.54 |
70,554 |
3 |
Approval of the Directors' Remuneration Report |
326,900,982 |
81.46 |
74,386,007 |
18.54 |
87.46 |
477,284 |
4 |
Election of |
396,165,343 |
98.62 |
5,556,799 |
1.38 |
87.55 |
42,131 |
5 |
Election of |
400,647,801 |
99.73 |
1,072,640 |
0.27 |
87.55 |
43,832 |
6 |
Election of |
398,247,371 |
99.15 |
3,424,603 |
0.85 |
87.54 |
92,299 |
7 |
Re-election of |
327,016,025 |
81.52 |
74,146,730 |
18.48 |
87.43 |
601,518 |
8 |
Re-election of |
383,925,736 |
95.57 |
17,796,001 |
4.43 |
87.55 |
42,536 |
9 |
Re-election of |
340,400,836 |
84.85 |
60,755,599 |
15.15 |
87.43 |
607,838 |
10 |
Re-election of |
399,665,278 |
99.49 |
2,051,202 |
0.51 |
87.55 |
47,793 |
11 |
Re-election of |
400,239,659 |
99.63 |
1,481,491 |
0.37 |
87.55 |
43,123 |
12 |
Re-election of Álvaro Gómez-Trénor Aguilar as a director of the Company |
398,255,592 |
99.15 |
3,410,195 |
0.85 |
87.54 |
98,486 |
13 |
Re-election of Thomas H Johnson as a director of the Company |
380,352,717 |
94.68 |
21,369,090 |
5.32 |
87.55 |
42,466 |
14 |
Re-election of |
396,872,734 |
98.79 |
4,849,967 |
1.21 |
87.55 |
41,572 |
15 |
Re-election of |
398,282,906 |
99.16 |
3,388,947 |
0.84 |
87.54 |
92,420 |
16 |
Re-election of |
397,432,894 |
98.93 |
4,289,121 |
1.07 |
87.55 |
42,258 |
17 |
Re-election of Mario Rotllant Solá as a director of the Company |
398,299,343 |
99.16 |
3,371,732 |
0.84 |
87.54 |
93,198 |
18 |
Re-election of |
395,888,495 |
98.55 |
5,826,476 |
1.45 |
87.55 |
49,302 |
19 |
Re-election of |
400,282,236 |
99.64 |
1,440,199 |
0.36 |
87.55 |
41,838 |
20 |
Reappointment of the Auditor |
394,397,371 |
98.18 |
7,312,398 |
1.82 |
87.55 |
54,504 |
21 |
Remuneration of the Auditor |
400,455,127 |
99.69 |
1,244,559 |
0.31 |
87.55 |
64,587 |
22 |
Political Donations |
400,327,265 |
99.84 |
634,426 |
0.16 |
87.38 |
802,582 |
23 |
Authority to allot new shares |
390,691,176 |
97.26 |
10,997,388 |
2.74 |
87.54 |
75,709 |
24 |
Waiver of mandatory offer provisions set out in Rule 9 of the Takeover Code (see note 4) |
183,391,655 |
78.07 |
51,524,688 |
21.93 |
51.20 |
166,847,930 |
25 |
Approval of Long Term Incentive Plan |
398,632,467 |
99.24 |
3,054,500 |
0.76 |
87.54 |
77,306 |
26 |
General authority to disapply pre-emption rights |
398,050,840 |
99.38 |
2,465,812 |
0.62 |
87.29 |
1,247,621 |
27 |
General authority to disapply pre-emption rights in connection with an acquisition or specified capital investment |
397,109,783 |
99.14 |
3,462,858 |
0.86 |
87.30 |
1,191,632 |
28 |
Authority to purchase own shares on market |
400,401,708 |
99.78 |
873,833 |
0.22 |
87.45 |
488,732 |
29 |
Authority to purchase own shares off market |
394,934,181 |
98.42 |
6,335,082 |
1.58 |
87.45 |
495,010 |
30 |
Notice period for general meetings other than annual general meetings |
390,811,804 |
97.29 |
10,895,895 |
2.71 |
87.55 |
56,574 |
Notes:
1 |
Votes "For" and "Against" are expressed as a percentage of votes received.
|
2 |
As at
|
3 |
A "Vote Withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
|
4 |
Resolution 24 was put to the AGM as a resolution of the shareholders of the Company other than |
Resolution 24, being the ordinary resolution to approve the waiver by the Panel on Takeovers and Mergers under Rule 9 of the City Code on Takeovers and Mergers (the "Rule 9 waiver") in connection with the Company's buyback programme was duly passed by 78.07% of the votes cast by the independent shareholders of the Company (being shareholders other than Olive and its presumed concert parties) with 21.93% of votes against. Resolution 24 is a standing agenda item at each Annual General Meeting to enable CCEP to exercise the authorities under Resolution 28 to purchase its own shares on market and Resolution 29 to purchase its own shares off market, which were passed with majorities of 99.78% and 98.42% respectively. This will enable CCEP to make use of the option to return value to shareholders through a possible future buyback programme. Had Resolution 24 not been passed, the Company would not have been able to effect such buyback programmes, as explained in the Notice of AGM and also in the Letter to Shareholders issued via RNS on
Olive is currently interested in 166,128,987 shares in the Company and the Waiver does not entitle Olive to be interested in a greater number of shares. The Waiver would allow Olive's interest in shares as a percentage of the Company's total shares to increase as a result of the exercise of the Company's authorities to purchase its own shares, but only to the extent that the resulting interest of Olive, together with any concert parties, in the shares of the Company did not then exceed 40.2797%.
In accordance with Listing Rule 14.3.6R, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
CONTACTS
Company Secretariat T +44 (0)20 7355 8406 |
Investor Relations T +44 (0)7970 145 218 |
Media Relations T +44 (0)7976 595 168 |
ABOUT CCEP
For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the